Related Experiment Videos
[Changes in hemoglobin in patients with hemolytic anemia].
G Pérez1, M E de la Peña, A Esparza
1División de Genética, Unidad de Investigación Biomédica, CMO, IMSS, Guadalajara, Jalisco, México.
Archivos De Investigacion Medica
|October 1, 1990
Summary
Thalassemia is the most common cause of hemolytic anemia in this patient group. This study highlights the significance of investigating hemoglobinopathies in specific populations.
Area of Science:
- Hematology
- Genetics
- Internal Medicine
Context:
- Hemolytic anemia and hemoglobinopathies are significant health concerns.
- Understanding the prevalence of specific hemoglobin alterations is crucial for diagnosis and management.
- This study focuses on a cohort of 129 patients with suspected or confirmed hemolytic anemia.
Purpose:
- To investigate the spectrum of hemoglobin (Hb) alterations in patients with hemolytic anemia.
- To determine the most frequent cause of hemolytic anemia within the studied population.
- To emphasize the importance of studying hemoglobinopathies in selected patient groups.
Summary:
- Over two years, 129 patients with hemolytic anemia or potential hemoglobinopathies were analyzed.
- Thalassemia was identified as the most frequent cause of hemolytic anemia.
- Other studied conditions included various forms of thalassemia, sickle cell disease (Hb S), unstable Hb, and Hereditary Persistence of Hb F.
Impact:
- The findings indicate that thalassemia is the primary hemoglobin alteration leading to hemolytic anemia in this population.
- This research underscores the necessity of detailed hemoglobinopathy studies in specific demographic groups.
- Results can inform diagnostic strategies and genetic counseling for affected individuals and families.